Aviad Friedman - Director, Oramed Pharmaceuticals Inc
As of January 5, 2022
Aviad Friedman Net Worth
- Net worth is estimated to be at least $133.74K
- Owns at least 22,191 units of Oramed Pharmaceuticals Inc stock
Aviad Friedman Trading
- Largest purchase of shares was 2,500 units , worth over $12.37K on August 13, 2018
- In total has made about 5 transactions over 5 years
- Usually trades in January, with the busiest year in 2017
Aviad Friedman
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Aviad Friedman Mailing Address
- Mailing address is Hadassa 6 Tel Aviv L3 6451306 Israel
Oramed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Nadav Kidron | 2020 | $439,076 | $220,582 | $569,062 | $539,131 | $1,767,851 |
| Nadav Kidron | 2019 | $419,460 | $224,975 | $398,910 | $507,750 | $1,551,095 |
| Nadav Kidron | 2018 | $436,310 | $148,795 | $522,569 | $442,326 | $1,550,000 |
| Miriam Kidron | 2020 | $305,840 | $70,000 | $299,506 | $13,354 | $688,700 |
| Miriam Kidron | 2019 | $267,386 | $123,149 | $211,128 | $14,503 | $616,166 |
| Miriam Kidron | 2018 | $273,595 | $46,614 | $253,204 | $13,643 | $587,056 |
| Avraham Gabay | 2020 | $130,554 | $15,591 | - | $44,912 | $191,418 |
| Avraham Gabay | 2019 | $32,122 | - | $73,928 | $9,441 | $115,491 |
| Joshua Hexter | 2020 | $190,801 | $12,169 | $351,128 | $54,735 | $608,833 |
| Joshua Hexter | 2019 | $52,848 | - | - | $9,022 | $61,870 |
| Joshua Hexter | 2018 | $161,002 | $26,895 | $269,196 | $50,505 | $507,598 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm
Oramed Pharmaceuticals Inc Insider Trading
- The most recent transaction was 3,000 units sold on May 10, 2022 by Arie Mayer worth over $76.8K
- In the last 13 years, insiders at Oramed Pharmaceuticals Inc sold an estimated value of $12.22M and bought an estimated value of $6.11M
- The most active traders are Miriam Kidron, Chief Scientific Officer, Nadav Kidron, President and CEO, and Leonard Sank, Director
- Insider trading is most common in February, with the busiest year in 2014
ORAMED PHARMACEUTICALS INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||